Keyphrases
Adverse Events
20%
Adverse Events Following Immunization
20%
Anti-RBD IgG
100%
Antibody Response
20%
Antibody Titer
20%
Antireceptor
60%
Blood Samples
20%
BNT162b2
100%
BNT162b2 Vaccine
40%
Confidence Interval
80%
COVID-19
20%
COVID-19 Vaccination
20%
Geometric Mean Titer
60%
Headache
20%
Healthcare Workers
20%
Humoral Response
20%
IgG Antibody
100%
Immunoglobulin G Antibodies
60%
Injection Site Reaction
20%
Multivariable Logistic Regression
20%
Neutralizing Antibodies
100%
Patient Demographics
20%
Patients with Hematological Malignancies
20%
Plasma Cell Disorders
100%
Receptor-binding Domain
60%
Response to COVID-19
20%
Severe Morbidity
20%
Significant Predictors
20%
Vaccination
20%
Vaccine Dose
40%
Medicine and Dentistry
Adverse Event
40%
Antibody Response
20%
COVID-19
20%
COVID-19 Vaccination
20%
Disease
100%
Headache
20%
Hematologic Malignancy
20%
Humoral Immunity
20%
Immunoglobulin G Antibody
100%
Injection Site Reaction
20%
Logistic Regression Analysis
20%
mRNA Vaccine
40%
Neutralizing Antibody
100%
Patient Population
20%
Plasma Cell
100%
Receptor Binding
60%
Biochemistry, Genetics and Molecular Biology
Antibody Response
20%
Binding Domain
60%
Humoral Immunity
20%
Immunoglobulin G
100%
Immunoglobulin G
60%
Messenger RNA
40%
Monospecific Antibody
60%
Neutralizing Antibody
100%
Plasma Cell
100%
Receptor Binding
60%
Titer
80%
Immunology and Microbiology
Antibody Response
20%
Antibody Titer
20%
COVID-19
40%
Humoral Immunity
20%
Immunoglobulin G Antibody
100%
Neutralizing Antibody
100%
Plasma Cell
100%
Receptor Binding
60%
Titer
60%
Vaccination Policy
60%
Vaccine Efficacy
80%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
40%
Disease
100%
Headache
20%
Hematologic Malignancy
20%
Immunoglobulin G Antibody
100%
Injection Site Reaction
20%
mRNA Vaccine
40%
Neutralizing Antibody
100%
Receptor
60%
Vaccination Policy
60%
Neuroscience
Headache
20%
Humoral Immunity
20%
Immunoglobulin G Antibody
100%
Neutralizing Antibody
100%
Plasma Cell
100%
Receptor Binding
60%